Drug Approval | December 12, 2022
Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Move to increase affordability and accessibility for heart failure patients across the country
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The approval further strengthens the Potassium Chloride franchise for the company.
Subscribe To Our Newsletter & Stay Updated
